Quest Diagnostics (DGX) Acquisitions (2009 - 2026)

Quest Diagnostics has reported Acquisitions for 17 years, with the latest figure at $38.0 million in Q1 2026.

• Quarterly Acquisitions changed N/A year-over-year to $38.0 million in Q1 2026, while the trailing twelve-month figure through Jun 2026 was $122.0 million (down 75.89% YoY) and the FY2025 annual result came in at $101.0 million, down 95.33% from the prior year.
• Acquisitions retreated to $38.0 million in Q1 2026 per DGX's latest filing, from $50.0 million in the prior quarter.
• Over five years, Acquisitions peaked at $578.0 million in Q2 2023 and troughed at $1.0 million in Q2 2022.
• A 5-year average of $130.4 million and a median of $44.0 million in 2022 frame the typical range for Acquisitions.
• The sharpest annual moves came in 2022 and 2023: Acquisitions tumbled 99.57% in 2022, then surged 57700.0% in 2023.
• Over 5 years, Acquisitions stood at $38.0 million in 2022, then tumbled by 94.74% to $2.0 million in 2023, then jumped by 19050.0% to $383.0 million in 2024, then plunged by 86.95% to $50.0 million in 2025, then dropped by 24.0% to $38.0 million in 2026.
• According to Business Quant data, Acquisitions over the past three periods registered $38.0 million, $50.0 million, and $34.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.